A targeting lentiviral vector for generation of CAR-T cells in vivo
Abstract Chimeric antigen receptor (CAR) T cell therapy has demonstrated remarkable therapeutic efficacy in treating cancer and autoimmune diseases. However, current CAR-T cell therapy requires ex vivo T cell engineering, which is both time-consuming and cost-prohibitive, adding complexity to the ov...
Shranjeno v:
| Principais autores: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Portfolio
2026-03-01
|
| Serija: | Scientific Reports |
| Teme: | |
| Online dostop: | https://doi.org/10.1038/s41598-025-17342-1 |
| Oznake: |
Brez oznak, prvi označite!
|